{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:35:03Z","timestamp":1791160503432,"version":"4.1.0"},"reference-count":41,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            <jats:italic>Yersinia pestis<\/jats:italic>\n            , the bacterium that causes plague, is a potential agent of biowarfare and bioterrorism. The aminoglycoside antibiotic streptomycin is the gold standard for treatment. However, this recommendation is based on scant animal and clinical data. We used an in vitro pharmacodynamic infection model to compare the efficacies of 10-day regimens of streptomycin versus the fluoroquinolone antibiotic levofloxacin for the treatment of\n            <jats:italic>Y. pestis<\/jats:italic>\n            infection and to evaluate for emergence of resistance. The human serum concentration-time profiles for standard clinical regimens of 1 g of streptomycin given every 12 h and 500 mg of levofloxacin given every 24 h were simulated. The growth fitness of drug-resistant mutants was examined in neutropenic and immunocompetent mouse thigh infection models. In the in vitro infection system, untreated bacteria grew from 10\n            <jats:sup>7<\/jats:sup>\n            to 10\n            <jats:sup>10<\/jats:sup>\n            CFU\/ml. Streptomycin therapy caused a 10\n            <jats:sup>5<\/jats:sup>\n            CFU\/ml reduction in the number of bacteria over 24 h, followed by regrowth with streptomycin-resistant mutants. Levofloxacin resulted in a 10\n            <jats:sup>7<\/jats:sup>\n            CFU\/ml reduction in the number of bacteria within 12 h, ultimately sterilizing the culture without resistance selection. In both the normal and neutropenic mouse infection models, streptomycin-resistant and wild-type strains were equally fit. However, 90% of levofloxacin-resistant isolates, cultured from the control in vitro infection arm, did not proliferate in the mouse models. Thus, the fluoroquinolone antibiotic levofloxacin was superior to streptomycin in our in vitro infection model. The majority of levofloxacin-resistant mutants were less fit than streptomycin-resistant and wild-type\n            <jats:italic>Y. pestis<\/jats:italic>\n            .\n          <\/jats:p>","DOI":"10.1128\/aac.00073-07","type":"journal-article","created":{"date-parts":[[2007,5,22]],"date-time":"2007-05-22T16:35:23Z","timestamp":1179851723000},"page":"2661-2667","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":26,"title":["Impact of Resistance Selection and Mutant Growth Fitness on the Relative Efficacies of Streptomycin and Levofloxacin for Plague Therapy"],"prefix":"10.1128","volume":"51","author":[{"given":"Arnold","family":"Louie","sequence":"first","affiliation":[{"name":"Emerging Infections and Host Defense Section, Ordway Research Institute, Albany, New York 12208"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Deziel","sequence":"additional","affiliation":[{"name":"Emerging Infections and Host Defense Section, Ordway Research Institute, Albany, New York 12208"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Liu","sequence":"additional","affiliation":[{"name":"Emerging Infections and Host Defense Section, Ordway Research Institute, Albany, New York 12208"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Drusano","sequence":"additional","affiliation":[{"name":"Emerging Infections and Host Defense Section, Ordway Research Institute, Albany, New York 12208"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","unstructured":"Biohazard 1999"},{"key":"e_1_3_2_3_2","first-page":"16S","volume":"88","year":"1990","unstructured":"Appel, G. B. 1990. Aminoglycoside nephrotoxicity. Am. J. Med.88(Suppl. C):16S-20S.","journal-title":"Am. J. Med."},{"key":"e_1_3_2_4_2","first-page":"423","volume":"13","year":"1914","unstructured":"Bacot, A. W., and C. J. Martin. 1914. Observations on the mechanism of the transmission of plague by fleas. J. Hyg.13(Plague Suppl. 3):423-439.","journal-title":"J. Hyg."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.7.1054"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.3.481"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/381545"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.6.797"},{"key":"e_1_3_2_9_2","first-page":"2691","year":"2005","unstructured":"Butler, T., and D. T. Dennis. 2005. Yersinia species, including plague, p. 2691-2701. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practices of infectious diseases, 6th ed. Elsevier Churchill Livingstone, Philadelphia, PA.","journal-title":"Principles and practices of infectious diseases"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.3.675"},{"key":"e_1_3_2_11_2","first-page":"1","volume":"45","year":"1996","unstructured":"Centers for Disease Control and Prevention. 1996. Prevention of plague. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep.45(RR-14):1-15.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_12_2","first-page":"380","volume":"278","year":"1997","unstructured":"Centers for Disease Control and Prevention. 1997. Fatal human plague. Morb. Mortal. Wkly. Rep.278:380-382.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1967.03130170165036"},{"key":"e_1_3_2_14_2","first-page":"21","year":"1997","unstructured":"Dennis, D., and F. Meier. 1997. Plague, p. 21-47. In C. R. Horsburgh and A. M. Nelson (ed.), Pathology of emerging infections. ASM Press, Washington, DC.","journal-title":"Pathology of emerging infections"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.5099-5106.2005"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/319281"},{"key":"e_1_3_2_17_2","first-page":"382","year":"1986","unstructured":"Edberg, S. C. 1986. The measurement of antibiotics in human body fluids: techniques and significance, p. 382-399. In V. Lorian (ed.), Antibiotics in laboratory medicine. Williams and Wilkins, Baltimore, MD.","journal-title":"Antibiotics in laboratory medicine"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.11.2646"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709043371004"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.mi.09.100155.001345"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1086\/424849"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.17.2281"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.17.2236"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200316814"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00090-06"},{"key":"e_1_3_2_26_2","first-page":"179","volume":"74","year":"1990","unstructured":"Leggett, J. E., S. Ebert, B. Fantin, and W. A. Craig. 1990. Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models. Scand. J. Infect. Dis.74:179-184.","journal-title":"Scand. J. Infect. Dis."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/92.3.273"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(53)90040-0"},{"key":"e_1_3_2_29_2","first-page":"2157","year":"2000","unstructured":"Medical Economics Company. 2000. Physicians\u2019 desk reference, p. 2157-2165. Medical Economics Company, Mantvale, NJ.","journal-title":"Physicians\u2019 desk reference"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1086\/500137"},{"key":"e_1_3_2_31_2","unstructured":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 1997"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.10.1.35"},{"key":"e_1_3_2_33_2","first-page":"1227","year":"1983","unstructured":"Poland, J. D. 1983. Plague, p. 1227-1237. In P. D. Hoeprich (ed.), Infectious diseases: a modern treatise of infectious processes. Harper & Row, Philadelphia, PA.","journal-title":"Infectious diseases: a modern treatise of infectious processes"},{"key":"e_1_3_2_34_2","first-page":"37","volume":"56","year":"1989","unstructured":"Rasoamanana, B., P. Coulanges, P. Michel, and N. Rasolofonirina. 1989. Sensitivity of Yersinia pestis to antibiotics: 277 strains isolated in Madagascar between 1926 and 1989. Arch. Inst. Pasteur Madagascar56:37-53.","journal-title":"Arch. Inst. Pasteur Madagascar"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/37.4.769"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/41.2.301"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(89)90247-2"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.9.2153"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0810.020354"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1984.03340310043018"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(98)00006-1"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.13.1037.34625"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00073-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00073-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T19:20:38Z","timestamp":1645471238000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00073-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1128\/AAC.00073-07"],"URL":"https:\/\/doi.org\/10.1128\/aac.00073-07","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"2007-01-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-05-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}